Gabriele Dallmann | 02/24/2011
Stig Moller Christensen, International Planning and CRO Manager at ALK-Abelló, joins Dr. Gabriele Dallmann, CEO of Pharmatching GmbH, to discuss patient recruitment & retention strategies.
He outlines the most crucial factors for pivotal studies and what he expects the sponsor on one hand and the external vendor, the CRO, on the other side have to deliver to expedite the recruitment. He discusses the challenges of developing new immunotherapies for patients with allergies. He also...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma & Health 2024
September 10 - 12, 2024
Düsseldorf, Germany
Register Now |
View Agenda |
Learn More
Temperature Control and Logistics North America Summit
September 10 - 12, 2024
Falls Church, VA
Register Now |
View Agenda |
Learn More